Medical articles
Lung cancer: an AI reads the scanners and guesses 26 months in advance the gain in survival of a treatment
In the phase III MARIPOSA trial, Altis Labs' IPRO tool detected a benefit from the sixteenth week that conventional imaging criteria had not seen come.